INTRODUCTION
Placental abruption, continues to be a common disorder in obstetric practice and an enigma too. Despite, the advances in obstetrics, there are no reliable tests or biomarkers to predict and prevent the occurrence of placental abruption which could still be a nightmare for the treating team. It is uniquely fraught with dangers to the mother as well as the baby.
It is reported to occur in 0.49 to 1.8% births [1] [2] [3] [4] and accounts for 12 to 15% of stillbirths [5] [6] [7] and 3% of NeoNatal Deaths (NND). [8] [9] [10] Maternal Mortality Ratio (MMR) due to placental abruption was reported to be seven times higher than the general MMR of 5.7 in a study even from a developed country. 11 Evidence from the United States and Norway indicates that the frequency is increasing. 3, 12 The frequency varies by gestational age at delivery, tenfold higher with very preterm gestations, sharply declining as pregnancy progresses towards term, 5.4% and 0.3% at preterm and term gestations respectively. 3, 13, 14 Department of Obstetrics & Gynaecology, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha-442102, Maharashtra, India Despite extensive research, the majority of cases of placental abruption continue to be of unknown cause. However it is known to be more commonly associated with previous placental abruption, uterine tumours, dietary deficiencies, especially folate, hypertensive disorders, polyhydramnios, oligoamnios, prolonged rupture of membranes, chorioamnionitis, short umbilical cord and sudden uterine decompression. 15, 16 Epidemiologic studies have revealed, that advanced maternal age, cigarette smoking, cocaine,, grand multiparity, previous spontaneous abortions, gestation with male fetus, gestation occurring in high altitude, and twinning are associated with placental abruption. 17, 19 The objectives of the present study were to study the cases of placental abruption so as to know the trends, associated factors maternal perinatal outcome so as to try decrease in morbidity and mortality in the mother as well as the baby even with low resources and get some insight into future research needed. Table 4 ). Of the total 211 perinatal deaths, 66 (31.4%) were NND, 84 (40%) macerated stillbirths and 61 (28.6%) fresh stillbirths. The trends in NND between gestation 28-32 weeks decreased from 25% (2 cases) in block A to 15% (5 cases) in block I, for gestation 33-36 weeks remained same 12.5% (1 case) in block A and 12.5% (3 cases) in block I also and with gestation >37 weeks actually increased from 12.5% to 18.3%, a matter of concern. Maternal case fatality has been fluctuating between 3-5% till 2004, contributed to 12-15% of overall maternal mortality, however there has been no maternal deaths due to placental abruption in last 7 years.
METHODS
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DISCUSSION
Placental abruption continues to be a serious, potentially life-threatening emergency even in modern era. Timely diagnosis and early, appropriate interventions are the major challenges, till the time causes can be identified and eliminated, so that the disorder is prevented. Of 66,459 deliveries, 667 (1%) were cases of placental abruption, increasing trends from 0.73 to 1.11% between 1985-1987 and 2009-2011 , reported by others also, Periente et al., 20 report a rise in incidence from 0.49 to 1.8% births. Researchers report increased risk among teenagers, 20 in women aged 35 years and older, [14] [15] [16] but others have found no association with age. 21 It is also not known whether age per se is a risk factor or a marker for other yet unknown risk factors. In the present study trends of teenagers were similar, but 63 (9.5%) women were of >30 years of age, higher than 5.7% overall obstetric cases, during the period of analysis. There were 246 (36.9%) primigravida, significantly less than overall 45% primigravida (P >0.002), 6.71% women had APH in previous pregnancy, 5-17% incidence has been reported by others also. 17, 22 Hypertension and multiple gestation have long been associated with increased risk of placental abruption and we too found the same. 15, 23 Association of hypertensive disorders was significantly higher (18.5%) than overall incidence of 12.5%, multiple pregnancy was 3.62%, double than of overall 1.5%.
Preterm gestation has been reported more often, (even up to 60%, by Rana et al., 24 40% by Chang et al. 25 and in the present analysis also, it was 37.2%, Ananth et al. 17 & Pariente et al 3 report that small gestational age and hypertensive disorders which reflect chronic vascular dysfunction have strong association with placental abruption, In the present study FGR cases were less than overall FGR cases. Coagulopathy is a well-known complication of placental abruption. In the present analysis coagulopathy was diagnosed in six (0.96%) cases.
Placental abruption is known to be significantly associated with adverse perinatal outcome such as congenital malformations, vasa previa, low APGAR scores at 1 and 5 min <7 and perinatal mortality. 3 In the present analysis overall PMR in cases of placental abruption was 316.3, increased from 275.8 in block A to 296 in block I, a matter of concern especially because CB have increased. The survival of babies born with birth weight more than 2.5 kg increased from 18.5% in block A to 28.8% to block I, but the survival of babies with birth weight of less than 1.5 kg decreased from 27% in block A to 21% in block I.
CB is more often required in women with placental abruption either because of continuing haemorrhage or other organ dysfunction and/or foetal distress. In the present analysis 55.92% women had vaginal birth less often than overall 70% (P value: 0.32) and 294 (44.08%) had CS, higher than overall 30% (P value: 0.16). Some women underwent CS even with dead baby in view of deteriating maternal condition.
The case fatality, has been fluctuating between 3 to 5% till 2004 and contribution to maternal deaths due to placental abruption to overall maternal deaths has been fluctuating between 12-15%. However, there has been no fatality in last 7 years. May be early decision to do CS did save some lives but with increased CB and increased in perinatal death also.
The sheet anchor of treatment in cases of placental abruption is resuscitation, termination of pregnancy with amniotomy and oxytocics, timely CS depending on maternal and foetal condition, and the same has been done with some increase in CB maternal survival improved but perinatal deaths have been persisting rather increased. Cases of placental abruption have been increasing, many with no obvious cause though some cases had risk factors like hypertension, multiple pregnancy, perinatal deaths have been more in last decade though maternal deaths could be prevented. Research needs also to continue about causes so that more can be done for prevention. Awareness needs to be amongst these women and health providers for early health seeking, early diagnosis and timely appropriate management.
